Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus

Journal of Clinical Microbiology

Volumn 41, Issue 9, 2003, Pages 4252-4258

  Wetter, Tracy J ^a,c,d   Hazen, Kevin C ^b   Cutler, Jim E ^c  

^a MONTANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^c CHILDREN S HOSPITAL   (United States)

^d The Research Institute for Children at Children's Hospital New Orleans   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; GLUCOSE; ITRACONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; CHEMICAL MODIFICATION; COLORIMETRY; CONIDIUM; CORRELATION ANALYSIS; CULTURE MEDIUM; DILUTION; DRUG SENSITIVITY; FUNGUS GROWTH; GERMINATION; GLUCOSE UTILIZATION; INOCULATION; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAPID SUSCEPTIBILITY ASSAY; SENSITIVITY AND SPECIFICITY; STANDARD; YEAST;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; GLUCOSE; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS;

ASPERGILLUS; ASPERGILLUS FUMIGATUS; ASPERGILLUS TERREUS; FUNGI;

EID: 0041418028     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.9.4252-4258.2003     Document Type: Article

References (16)

1. Brajtburg, J., W. G. Powderly, G. S. Kobayashi, and G. Medoff. 1990. Amphotericin B: current understanding of mechanisms of action. Antimicrob. Agents Chemother. 34:183-188.
2. Dannauoui, E. 2001. Acquired itraconazole resistance in Aspergilltis fumigatus. J. Antimicrob. Chemother. 47:333-340.
3. Dannauoui, E., E. Borel, F. Persat, M. A. Piens, and S. Picot. 2000. Amphotericin B resistance of Aspergillus terreus in murine model of disseminated aspergillosis. J. Med. Microbiol. 49:601-606.
4. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781-805.
5. Denning, D. W., P. Ribaud, N. Milpied, D. Caillot, R. Herbrecht, E. Thiel, A. Haas, M. Ruhnke, and H. Lode. 2002. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin. Infect. Dis. 34:563-571.
6. Denning, D. W., S. A. Radford, K. L. Oakley, E. M. Johnson, and D. W. Warnock. 1997. Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection. J. Antimicrob. Chemother. 40:401-414.
7. Iwen, P. C., M. E. Rupp, A. N. Langnas, E. C. Reed, and S. H. Hinrichs. 1998. Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature. Clin. Infect. Dis. 26:1092-1097.
8. Johnson, E. M., K. L. Oakley, S. A. Radford, C. B. Moore, P. Warn, D. W. Warnock, and D. W. Denning. 2000. Lack of correlation of in vitro amphotericin B susceptibility testing with outcome in a murine model of Aspergillus infection. J. Antimicrob. Chemother. 45:85-93.
9. Kwon-Chung, K. J., and J. E. Bennett. 1992. Aspergillosis, p. 201-247. In C. Carr (ed.), Medical mycology. Lea and Febiger, London, United Kingdom.
10. Marichal, P., J. Gorrens, and H. Vanden Bosseche. 1985. The action of itraconazole and ketoconazole on growth and sterol synthesis in Aspergillus fumigatus and Aspergillus niger. Sabouraudia 23:13-21.
11. Moore, C. B., N. Sayers, J. Mosquera, J. Slaven, and D. W. Denning. 2000. Antifungal drug resistance in Aspergillus. J. Infect. 41:203-220.
12. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard, NCCLS document M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
13. National Committee for Clinical Laboratory Standards. 1998. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi; proposed standard, NCCLS document M38-P. National Committee for Clinical Laboratory Standards, Wayne, Pa.
14. Riesselman, M. H., K. C. Hazen, and J. E. Cutler. 2000. Determination of antifungal MICs by a rapid susceptibility assay. J. Clin. Microbiol. 38:333-340.
15. Stone, E. A., H. B. Fung, and H. L. Kirschenbaum. 2002. Caspofungin: an echinocandin antifungal agent. Clin. Ther. 24:351-377.
16. Vanden Bossche, H. 1985. Biochemical targets for antifungal azole derivatives: hypothesis on the mode of action, p. 313-351. In M. R. McGinnis (ed.), Current topics in medical mycology, vol. 1. Springer-Verlag, New York, N.Y.